In this study, we identified a mitochondrial factor, C20orf7, with oncogenic properties, and investigated the role of C20orf7 in vitro and in vivo, to demonstrate that it could serve as a therapeutic target in colon cancer. Here, NDUFAF5 is linked to colonic neoplasm.